Paediatric Committee (PDCO): 23-26 April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 April 2024 to 26 April 2024

Submitted by Anonymous (not verified) on 23 April 2024 - 10:59

Paediatric Committee (PDCO): 23-26 April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 April 2024 to 26 April 2024

Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 22 April 2024 - 15:31

Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 22 April 2024 - 15:00

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness